UK markets close in 5 hours 8 minutes

GenSight Biologics S.A. (SIGHTP.XC)

Cboe UK - Cboe UK Real-time price. Currency in EUR
Add to watchlist
0.5400-0.0130 (-2.35%)
As of 04:29PM BST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-26,220
-26,220
-27,625
-28,617
-34,015
Depreciation & amortisation
2,179
2,179
1,061
928
926
Stock-based compensation
587
587
-3,364
4,834
3,455
Change in working capital
2,454
2,454
-3,916
4,841
5,567
Other working capital
-24,673
-24,673
-34,005
-17,171
-15,050
Other non-cash items
-3,689
-3,689
120
858
8,987
Net cash provided by operating activities
-24,663
-24,663
-33,753
-17,139
-15,044
Cash flows from investing activities
Investments in property, plant and equipment
-10
-10
-252
-32
-6
Net cash used for investing activities
209
209
172
-16
-376
Net change in cash
-8,595
-8,595
-33,487
6,584
18,439
Cash at beginning of period
10,610
10,610
44,288
37,943
19,250
Cash at end of period
2,134
2,134
10,610
44,288
37,943
Free cash flow
Operating cash flow
-24,663
-24,663
-33,753
-17,139
-15,044
Capital expenditure
-10
-10
-252
-32
-6
Free cash flow
-24,673
-24,673
-34,005
-17,171
-15,050